76595520
Jun 3, 2004
May 8, 2007
Pharmaceutical preparations for treating cardiovascular diseases, namely, ischemic heart diseases, cardiac insufficiency, hypertension, arrhythmias, thrombosis, atherosclerosis, peripheral arterial disease, restenosis, and shock resuscitation; venous disorders, namely, deep venous thrombosis; cerebral diseases, namely, stroke, neurodegenerative pathologies, Alzheimer's disease, Parkinson's disease, sleep pathologies, depression, anxiousness, psychotic disorders, epilepsy, migraine headaches; inflammatory diseases, namely, osteoarthritis, rheumatoid arthritis, alkylosing spondylitis, tendonitis, acute gout, inflammatory bowel diseases, prostates, dysmenorrhoea, post-traumatic oedema, fever, cancer, colorectal cancer, ovarian cancer, breast carcinoma, leukemia, prostate cancer, neuroblastoma, apoptosis processes, cancer cachexia syndrome; inhibiting tumor cell growth; for use as chemotherapy efficacy enhancers; immune diseases induced by virus, namely, herpes, herpes zoster and Aids; diabetes, cholesterol and lipid disorders; eye disease, retina ischemic, retina degeneration, glaucoma, and dry eye; sexual dysfunction, angiogenesis, inner ear disease, neuropathic pain, pain during anaesthesia, pulmonary diseases, cystic fibrosis, pulmonary hypertension, exocrine gland disease; antiseptic preparations; dietary food supplements; animal feed additive for use as a nutritional supplement; and dressings for wounds, burns and surgical use
Pharmaceuticals